Articles

Tomatoes II (G 0002/12) and Broccoli II (G 0002/13): European Patent Office’s decisions

Tomatoes II (G 0002/12) and Broccoli II (G 0002/13): European Patent Office’s decisions

Tomatoes II (G 0002/12) and Broccoli II (G 0002/13): European Patent Office’s decisions

27.03.2015 BE law

The Enlarged Board of Appeal of the European Patent Office has taken two decisions this Wednesday (25 March 2015) highly anticipated by the agrochemical industry in the case Tomatoes II (G 0002/12) and Broccoli II (G 0002/13).

Also available in Dutch and French.

The Board held that a patent application for a plant or plant material (such as a part of a plant or fruit) – not limited to a plant variety – could not be refused on the ground that this plant or that plant material would (only) come from an essentially biological process.  

Under article 53 b) of the European Patent Convention an essentially biological process is namely not patentable. A patent application for a product can only be examined on the basis of conditions for this class of inventions and not by taking into account considerations related to process patents.

These two decisions raise some of the uncertainty that prevailed for more than a decade as to the object of patents on plants in favor of patent applicants.

 

Team

Related news

20.11.2018 NL law
Seminar 'Personal data from a broader perspective: overlap inside and outside the privacy domain'

Seminar - On 20 November 2018, Stibbe will host a seminar on privacy. Several Stibbe lawyers will discuss personal data from a broader perspective and the overlap that can occur inside and outside the legal privacy domain.

Read more

21.03.2019 EU law
Ignace Vernimme, Floris ten Have and Manuel Campolini are speakers during the Legal Affairs Conference.

Speaking slot - Ignace Vernimme, IP Partner at Stibbe Brussels, moderates a roundtable discussion on 'second medical use patents'. Manuel Campolini, of-counsel at Stibbe Brussels, co-moderates this session. Floris ten Have, Competition and Regulation Partner at Stibbe Amsterdam, chairs a session on opportunities and challenges for biosimilar medicine developers.

Read more

21.03.2019 NL law
15 aspects of Brexit you did not know

Short Reads - A Brexit without a deal, or with a deal that does not cover all relevant aspects, is still a potential scenario. We have highlighted a number of unexpected legal consequences of Brexit in such a no deal or incomplete deal scenario.

Read more

03.10.2018 NL law
Thirteen legal tips for start-ups and scale-ups -Takeaways from Stibbe's 'Scale Up Academy Accenture Innovation Awards' legal workshop

Articles - On Thursday August 30, Stibbe, in cooperation with Accenture Innovation Awards 2017 finalist Somnox, hosted a legal workshop as part of the 'Scale Up Academy of the Accenture Innovation Awards'. The purpose of the event was to make start-ups and scale-ups aware of the legal challenges that may arise in their infancy. 

Read more

Our website uses functional cookies for the functioning of the website and analytic cookies that enable us to generate aggregated visitor data. We also use other cookies, such as third party tracking cookies - please indicate whether you agree to the use of these other cookies:

Privacy – en cookieverklaring